Effect of Metformin on Bcl-2/Bax Expression Ratio and Endometrial Implants: A Mouse Model in Endometriosis Study

Background: Endometriosis is a gynaecological disorder characterised by the presence of endometrial tissue outside the uterine cavity. Apoptosis, regulated by the balance of Bcl-2/Bax, plays an important role in the endometrial improvement. Metformin, an insulin sensitizer that is known to have bene...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Inu Mulyantoro, Oktoria Indrapraja, Widjiati Widjiati, Noor Pramono Noerpramana
Formato:	article
Lenguaje:	EN
Publicado:	Diponegoro University 2020
Materias:	metformin endometriosis, bcl-2/bax ratio, endometriosis implants Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/8ddca4a25a444a1295c112c13a51678e
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:8ddca4a25a444a1295c112c13a51678e
record_format	dspace
spelling	oai:doaj.org-article:8ddca4a25a444a1295c112c13a51678e2021-11-05T16:47:43ZEffect of Metformin on Bcl-2/Bax Expression Ratio and Endometrial Implants: A Mouse Model in Endometriosis Study2503-217810.14710/jbtr.v6i2.8113https://doaj.org/article/8ddca4a25a444a1295c112c13a51678e2020-08-01T00:00:00Zhttps://ejournal2.undip.ac.id/index.php/jbtr/article/view/8113https://doaj.org/toc/2503-2178Background: Endometriosis is a gynaecological disorder characterised by the presence of endometrial tissue outside the uterine cavity. Apoptosis, regulated by the balance of Bcl-2/Bax, plays an important role in the endometrial improvement. Metformin, an insulin sensitizer that is known to have beneficial effect in the endometriosis treatment, is expected to lower Bcl-2/Bax expression ratio and reduce endometrial implants. Objective: To explore the effect of metformin on the Bcl-2/Bax expression ratio and endometrial implant area of endometriosis-induced mice. Methods: This experimental study used 3-month old 33 BALB/c mice of endometriosis that were randomly and equally divided into three groups (P0, P1, and P2). On the 15th day, the P0 group was first terminated for Bcl-2/Bax examination and the size of endometrial implants. The P1 group was given aquabidest, whereas the P2 group was given metformin 4 mg/day for 14 days. The immunohistochemistry of Bcl-2/Bax expression were performed from cavum abdomen and pelvis peritoneal tissues of the mice and measured by the Remmele Scale Index, whereas the extracted mice’ endometrial implants were analysed with computer tracing method. All data normality test was calculated with Shapiro-Wilk test. The mean difference test of all groups was analysed using the one-way ANOVA test, whereas the mean difference test between groups was completed using the Unpaired T-test (LSD/Least Significance Difference). Results: The Bcl-2/Bax expression ratio and endometrial implant area in the P2 group were significantly lower compared to P0 and P1 (p<0.001). There were no significant differences in the Bcl-2/Bax expression ratio or endometrial implant area in P0 and P1 (p>0.05) Conclusion: Metformin may be a potential effective drug treatment for endometriosis by decreasing Bcl-2/Bax expression ratio and endometrial implants.Inu MulyantoroOktoria IndraprajaWidjiati WidjiatiNoor Pramono NoerpramanaDiponegoro Universityarticlemetforminendometriosis, bcl-2/bax ratio, endometriosis implantsMedicine (General)R5-920ENJournal of Biomedicine and Translational Research, Vol 6, Iss 2, Pp 53-58 (2020)
institution	DOAJ
collection	DOAJ
language	EN
topic	metformin endometriosis, bcl-2/bax ratio, endometriosis implants Medicine (General) R5-920
spellingShingle	metformin endometriosis, bcl-2/bax ratio, endometriosis implants Medicine (General) R5-920 Inu Mulyantoro Oktoria Indrapraja Widjiati Widjiati Noor Pramono Noerpramana Effect of Metformin on Bcl-2/Bax Expression Ratio and Endometrial Implants: A Mouse Model in Endometriosis Study
description	Background: Endometriosis is a gynaecological disorder characterised by the presence of endometrial tissue outside the uterine cavity. Apoptosis, regulated by the balance of Bcl-2/Bax, plays an important role in the endometrial improvement. Metformin, an insulin sensitizer that is known to have beneficial effect in the endometriosis treatment, is expected to lower Bcl-2/Bax expression ratio and reduce endometrial implants. Objective: To explore the effect of metformin on the Bcl-2/Bax expression ratio and endometrial implant area of endometriosis-induced mice. Methods: This experimental study used 3-month old 33 BALB/c mice of endometriosis that were randomly and equally divided into three groups (P0, P1, and P2). On the 15th day, the P0 group was first terminated for Bcl-2/Bax examination and the size of endometrial implants. The P1 group was given aquabidest, whereas the P2 group was given metformin 4 mg/day for 14 days. The immunohistochemistry of Bcl-2/Bax expression were performed from cavum abdomen and pelvis peritoneal tissues of the mice and measured by the Remmele Scale Index, whereas the extracted mice’ endometrial implants were analysed with computer tracing method. All data normality test was calculated with Shapiro-Wilk test. The mean difference test of all groups was analysed using the one-way ANOVA test, whereas the mean difference test between groups was completed using the Unpaired T-test (LSD/Least Significance Difference). Results: The Bcl-2/Bax expression ratio and endometrial implant area in the P2 group were significantly lower compared to P0 and P1 (p<0.001). There were no significant differences in the Bcl-2/Bax expression ratio or endometrial implant area in P0 and P1 (p>0.05) Conclusion: Metformin may be a potential effective drug treatment for endometriosis by decreasing Bcl-2/Bax expression ratio and endometrial implants.
format	article
author	Inu Mulyantoro Oktoria Indrapraja Widjiati Widjiati Noor Pramono Noerpramana
author_facet	Inu Mulyantoro Oktoria Indrapraja Widjiati Widjiati Noor Pramono Noerpramana
author_sort	Inu Mulyantoro
title	Effect of Metformin on Bcl-2/Bax Expression Ratio and Endometrial Implants: A Mouse Model in Endometriosis Study
title_short	Effect of Metformin on Bcl-2/Bax Expression Ratio and Endometrial Implants: A Mouse Model in Endometriosis Study
title_full	Effect of Metformin on Bcl-2/Bax Expression Ratio and Endometrial Implants: A Mouse Model in Endometriosis Study
title_fullStr	Effect of Metformin on Bcl-2/Bax Expression Ratio and Endometrial Implants: A Mouse Model in Endometriosis Study
title_full_unstemmed	Effect of Metformin on Bcl-2/Bax Expression Ratio and Endometrial Implants: A Mouse Model in Endometriosis Study
title_sort	effect of metformin on bcl-2/bax expression ratio and endometrial implants: a mouse model in endometriosis study
publisher	Diponegoro University
publishDate	2020
url	https://doaj.org/article/8ddca4a25a444a1295c112c13a51678e
work_keys_str_mv	AT inumulyantoro effectofmetforminonbcl2baxexpressionratioandendometrialimplantsamousemodelinendometriosisstudy AT oktoriaindrapraja effectofmetforminonbcl2baxexpressionratioandendometrialimplantsamousemodelinendometriosisstudy AT widjiatiwidjiati effectofmetforminonbcl2baxexpressionratioandendometrialimplantsamousemodelinendometriosisstudy AT noorpramononoerpramana effectofmetforminonbcl2baxexpressionratioandendometrialimplantsamousemodelinendometriosisstudy
_version_	1718444111815507968

Effect of Metformin on Bcl-2/Bax Expression Ratio and Endometrial Implants: A Mouse Model in Endometriosis Study

Ejemplares similares